Search in:

Advanced search

Drug Design, Development and Therapy Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway

Longfei YangDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Ying CuiDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Jianjun ShenDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Fang LinDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Xi WangDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Min LongDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Junxia WeiDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China

Huizhong ZhangDepartment of Medical Laboratory and Research Center, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of ChinaCorrespondence[email protected]

show all

Pages 1319-1330 | Published online: 02 Mar 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CovelerALBatesNEDisisMLProgress in the development of a therapeutic vaccine for breast cancerBreast Cancer20102253624367164
PubMedGoogle Scholar
KoziołMPüsküllüogluMZygulskaAPARP inhibitors and their role in the therapy of triple-negative metastatic breast cancerPrzegl Lek2012696265270 Polish23094440
PubMedGoogle Scholar
LadjemiMZJacotWChardèsTPèlegrinANavarro-TeulonIAnti-HER2 vaccines: new prospects for breast cancer therapyCancer Immunol Immunother20105991295131220532501
PubMed Web of Science ®Google Scholar
MurphyCGMorrisPGRecent advances in novel targeted therapies for HER2-positive breast cancerAnticancer Drugs201223876577622824822
PubMed Web of Science ®Google Scholar
WickiARochlitzCTargeted therapies in breast cancerSwiss Med Wkly2012142w1355022544433
PubMed Web of Science ®Google Scholar
Molnar-StanciuDGuimasVBensalemAThiery-VuilleminATargeted therapy and breast cancer: state of the artPathol Biol (Paris)2012604254263 French22728007
PubMedGoogle Scholar
BoohakerRJLeeMWVishnubhotlaPPerezJMKhaledARThe use of therapeutic peptides to target and to kill cancer cellsCurr Med Chem201219223794380422725698
PubMed Web of Science ®Google Scholar
ThundimadathilJCancer treatment using peptides: current therapies and future prospectsJ Amino Acids2012201296734
Google Scholar
CraikDJFairlieDPLirasSPriceDThe future of peptide-based drugsChem Biol Drug Des201381113614723253135
PubMed Web of Science ®Google Scholar
TakahashiTTAustinRJRobertsRWmRNA display: ligand discovery, interaction analysis and beyondTrends Biochem Sci200328315916512633996
PubMed Web of Science ®Google Scholar
WilsonDSKeefeADSzostakJWThe use of mRNA display to select high-affinity protein-binding peptidesProc Natl Acad Sci U S A20019873750375511274392
PubMed Web of Science ®Google Scholar
IkedaSSaitoISugiyamaHFacile synthesis of puromycin-tethered oligonucleotides at the 3′-endTetrahedron Lett19983959755978
Web of Science ®Google Scholar
Miyamoto-SatoEYanagawaHPuromycin technology for in vitro evolution and proteome explorationViva Origino2006334148154
Google Scholar
Miyamoto-SatoETakashimaHFuseSHighly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteinsNucleic Acids Res20033115e7812888530
PubMed Web of Science ®Google Scholar
WangHLiuRAdvantages of mRNA display selections over other selection techniques for investigation of protein-protein interactionsExpert Rev Proteomics20118333534621679115
PubMed Web of Science ®Google Scholar
ShiheidoHTakashimaHDoiNYanagawaHmRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interactionPLoS One201163e1789821423613
PubMed Web of Science ®Google Scholar
AlbericioFKrugerHGTherapeutic peptidesFuture Med Chem20124121527153122917241
PubMed Web of Science ®Google Scholar
WadePAMethyl CpG-binding proteins and transcriptional repressionBio Essays2001231211311137
PubMed Web of Science ®Google Scholar
SansomOJMaddisonKClarkeARMechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancerNat Clin Pract Oncol20074530531517464338
PubMedGoogle Scholar
WangZWanLZhongJCDC20: a potential novel therapeutic target for cancer treatmentCurr Pharm Des201319183210321423151139
PubMed Web of Science ®Google Scholar
AdkinsNLGeorgelPTMECP2: structure and functionBiochem Cell Biol201189111121326358
PubMed Web of Science ®Google Scholar
Ghavifekr FakhrMFarshdousti HaghMShanehbandiDBaradaranBDNA methylation pattern as important epigenetic criterion in cancerGenet Res Int2013201331756924455281
PubMedGoogle Scholar
NanXNgHHJohnsonCATranscriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complexNature199839366833863899620804
PubMed Web of Science ®Google Scholar
LeeEYMullerWJOncogenes and tumor suppressor genesCold Spring Harb Perspect Biol2010210a00323620719876
PubMed Web of Science ®Google Scholar
LacroixMToillonR-ALeclercqGp53 and breast cancer, an updateEndocr Relat Cancer200613229332516728565
PubMed Web of Science ®Google Scholar
PetrocelliTSlingerlandJMPTEN deficiency: a role in mammary carcinogenesisBreast Cancer Res20013635636011737885
PubMed Web of Science ®Google Scholar
McCubreyJASteelmanLSAbramsSLRoles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceAdv Enzyme Regul200646200624927916854453
PubMedGoogle Scholar
Blanco-AparicioCRennerOLealJFCarneroAPTEN, more than the AKT pathwayCarcinogenesis20072871379138617341655
PubMed Web of Science ®Google Scholar
GhobrialIMWitzigTEAdjeiAATargeting apoptosis pathways in cancer therapyCA Cancer J Clin200555317819415890640
PubMed Web of Science ®Google Scholar
CosentinoKGarcía-SáezAJMitochondrial alterations in apoptosisChem Phys Lipids2014181627524732580
PubMed Web of Science ®Google Scholar
Shamas-DinAKaleJLeberBAndrewsDWMechanisms of action of Bcl-2 family proteinsCold Spring Harb Perspect Biol201354a00871423545417
PubMed Web of Science ®Google Scholar
García-SáezAJThe secrets of the Bcl-2 familyCell Death Differ201219111733174022935609
PubMed Web of Science ®Google Scholar
ScorranoLKorsmeyerSJMechanisms of cytochrome c release by proapoptotic Bcl-2 family membersBiochem Biophys Res Commun2003304343744412729577
PubMed Web of Science ®Google Scholar
McIlwainDRBergerTMakTWCaspase functions in cell death and diseaseCold Spring Harb Perspect Biol201354a00865623545416
PubMed Web of Science ®Google Scholar
FiandaloMVKyprianouNCaspase control: protagonists of cancer cell apoptosisExp Oncol201234316517523070001
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date